Elite Pharmaceuticals Inc. (OTCMKTS:ELTP - Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $0.67, but opened at $0.70. Elite Pharmaceuticals shares last traded at $0.72, with a volume of 860,448 shares.
Elite Pharmaceuticals Stock Up 10.7%
The company has a current ratio of 3.27, a quick ratio of 1.90 and a debt-to-equity ratio of 0.12. The company has a market cap of $792.72 million, a price-to-earnings ratio of -37.10 and a beta of 0.17. The firm's fifty day simple moving average is $0.51 and its 200 day simple moving average is $0.50.
Elite Pharmaceuticals Company Profile
(
Get Free Report)
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
See Also
Before you consider Elite Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elite Pharmaceuticals wasn't on the list.
While Elite Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
